Drug combo vs standard therapy: which works better for liver cancer?
Disease control
Terminated
This study aimed to compare two treatment approaches for intermediate-stage liver cancer that can't be cured surgically. It tested whether a combination of two cancer drugs (regorafenib and pembrolizumab) works better than standard liver-directed treatments (TACE or TARE). The tr…
Phase: PHASE3 • Sponsor: Translational Research in Oncology • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC